Cargando…
Interobserver agreement on definition of the target volume in stereotactic radiotherapy for pancreatic adenocarcinoma using different imaging modalities
PURPOSE: The aim of this study was to evaluate interobserver agreement (IOA) on target volume definition for pancreatic cancer (PACA) within the Radiosurgery and Stereotactic Radiotherapy Working Group of the German Society of Radiation Oncology (DEGRO) and to identify the influence of imaging modal...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10598103/ https://www.ncbi.nlm.nih.gov/pubmed/37268767 http://dx.doi.org/10.1007/s00066-023-02085-7 |
_version_ | 1785125480764014592 |
---|---|
author | Gkika, E. Kostyszyn, D. Fechter, T. Moustakis, C. Ernst, F. Boda-Heggemann, J. Sarria, G. Dieckmann, K. Dobiasch, S. Duma, M. N. Eberle, F. Kroeger, K. Häussler, B. Izaguirre, V. Jazmati, D. Lautenschläger, S. Lohaus, F. Mantel, F. Menzel, J. Pachmann, S. Pavic, M. Radlanski, K. Riesterer, O. Gerum, S. Röder, F. Willner, J. Barczyk, S. Imhoff, D. Blanck, O. Wittig, A. Guckenberger, M. Grosu, Anca-L. Brunner, T. B. |
author_facet | Gkika, E. Kostyszyn, D. Fechter, T. Moustakis, C. Ernst, F. Boda-Heggemann, J. Sarria, G. Dieckmann, K. Dobiasch, S. Duma, M. N. Eberle, F. Kroeger, K. Häussler, B. Izaguirre, V. Jazmati, D. Lautenschläger, S. Lohaus, F. Mantel, F. Menzel, J. Pachmann, S. Pavic, M. Radlanski, K. Riesterer, O. Gerum, S. Röder, F. Willner, J. Barczyk, S. Imhoff, D. Blanck, O. Wittig, A. Guckenberger, M. Grosu, Anca-L. Brunner, T. B. |
author_sort | Gkika, E. |
collection | PubMed |
description | PURPOSE: The aim of this study was to evaluate interobserver agreement (IOA) on target volume definition for pancreatic cancer (PACA) within the Radiosurgery and Stereotactic Radiotherapy Working Group of the German Society of Radiation Oncology (DEGRO) and to identify the influence of imaging modalities on the definition of the target volumes. METHODS: Two cases of locally advanced PACA and one local recurrence were selected from a large SBRT database. Delineation was based on either a planning 4D CT with or without (w/wo) IV contrast, w/wo PET/CT, and w/wo diagnostic MRI. Novel compared to other studies, a combination of four metrics was used to integrate several aspects of target volume segmentation: the Dice coefficient (DSC), the Hausdorff distance (HD), the probabilistic distance (PBD), and the volumetric similarity (VS). RESULTS: For all three GTVs, the median DSC was 0.75 (range 0.17–0.95), the median HD 15 (range 3.22–67.11) mm, the median PBD 0.33 (range 0.06–4.86), and the median VS was 0.88 (range 0.31–1). For ITVs and PTVs the results were similar. When comparing the imaging modalities for delineation, the best agreement for the GTV was achieved using PET/CT, and for the ITV and PTV using 4D PET/CT, in treatment position with abdominal compression. CONCLUSION: Overall, there was good GTV agreement (DSC). Combined metrics appeared to allow a more valid detection of interobserver variation. For SBRT, either 4D PET/CT or 3D PET/CT in treatment position with abdominal compression leads to better agreement and should be considered as a very useful imaging modality for the definition of treatment volumes in pancreatic SBRT. Contouring does not appear to be the weakest link in the treatment planning chain of SBRT for PACA. |
format | Online Article Text |
id | pubmed-10598103 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-105981032023-10-26 Interobserver agreement on definition of the target volume in stereotactic radiotherapy for pancreatic adenocarcinoma using different imaging modalities Gkika, E. Kostyszyn, D. Fechter, T. Moustakis, C. Ernst, F. Boda-Heggemann, J. Sarria, G. Dieckmann, K. Dobiasch, S. Duma, M. N. Eberle, F. Kroeger, K. Häussler, B. Izaguirre, V. Jazmati, D. Lautenschläger, S. Lohaus, F. Mantel, F. Menzel, J. Pachmann, S. Pavic, M. Radlanski, K. Riesterer, O. Gerum, S. Röder, F. Willner, J. Barczyk, S. Imhoff, D. Blanck, O. Wittig, A. Guckenberger, M. Grosu, Anca-L. Brunner, T. B. Strahlenther Onkol Original Article PURPOSE: The aim of this study was to evaluate interobserver agreement (IOA) on target volume definition for pancreatic cancer (PACA) within the Radiosurgery and Stereotactic Radiotherapy Working Group of the German Society of Radiation Oncology (DEGRO) and to identify the influence of imaging modalities on the definition of the target volumes. METHODS: Two cases of locally advanced PACA and one local recurrence were selected from a large SBRT database. Delineation was based on either a planning 4D CT with or without (w/wo) IV contrast, w/wo PET/CT, and w/wo diagnostic MRI. Novel compared to other studies, a combination of four metrics was used to integrate several aspects of target volume segmentation: the Dice coefficient (DSC), the Hausdorff distance (HD), the probabilistic distance (PBD), and the volumetric similarity (VS). RESULTS: For all three GTVs, the median DSC was 0.75 (range 0.17–0.95), the median HD 15 (range 3.22–67.11) mm, the median PBD 0.33 (range 0.06–4.86), and the median VS was 0.88 (range 0.31–1). For ITVs and PTVs the results were similar. When comparing the imaging modalities for delineation, the best agreement for the GTV was achieved using PET/CT, and for the ITV and PTV using 4D PET/CT, in treatment position with abdominal compression. CONCLUSION: Overall, there was good GTV agreement (DSC). Combined metrics appeared to allow a more valid detection of interobserver variation. For SBRT, either 4D PET/CT or 3D PET/CT in treatment position with abdominal compression leads to better agreement and should be considered as a very useful imaging modality for the definition of treatment volumes in pancreatic SBRT. Contouring does not appear to be the weakest link in the treatment planning chain of SBRT for PACA. Springer Berlin Heidelberg 2023-06-02 2023 /pmc/articles/PMC10598103/ /pubmed/37268767 http://dx.doi.org/10.1007/s00066-023-02085-7 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Original Article Gkika, E. Kostyszyn, D. Fechter, T. Moustakis, C. Ernst, F. Boda-Heggemann, J. Sarria, G. Dieckmann, K. Dobiasch, S. Duma, M. N. Eberle, F. Kroeger, K. Häussler, B. Izaguirre, V. Jazmati, D. Lautenschläger, S. Lohaus, F. Mantel, F. Menzel, J. Pachmann, S. Pavic, M. Radlanski, K. Riesterer, O. Gerum, S. Röder, F. Willner, J. Barczyk, S. Imhoff, D. Blanck, O. Wittig, A. Guckenberger, M. Grosu, Anca-L. Brunner, T. B. Interobserver agreement on definition of the target volume in stereotactic radiotherapy for pancreatic adenocarcinoma using different imaging modalities |
title | Interobserver agreement on definition of the target volume in stereotactic radiotherapy for pancreatic adenocarcinoma using different imaging modalities |
title_full | Interobserver agreement on definition of the target volume in stereotactic radiotherapy for pancreatic adenocarcinoma using different imaging modalities |
title_fullStr | Interobserver agreement on definition of the target volume in stereotactic radiotherapy for pancreatic adenocarcinoma using different imaging modalities |
title_full_unstemmed | Interobserver agreement on definition of the target volume in stereotactic radiotherapy for pancreatic adenocarcinoma using different imaging modalities |
title_short | Interobserver agreement on definition of the target volume in stereotactic radiotherapy for pancreatic adenocarcinoma using different imaging modalities |
title_sort | interobserver agreement on definition of the target volume in stereotactic radiotherapy for pancreatic adenocarcinoma using different imaging modalities |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10598103/ https://www.ncbi.nlm.nih.gov/pubmed/37268767 http://dx.doi.org/10.1007/s00066-023-02085-7 |
work_keys_str_mv | AT gkikae interobserveragreementondefinitionofthetargetvolumeinstereotacticradiotherapyforpancreaticadenocarcinomausingdifferentimagingmodalities AT kostyszynd interobserveragreementondefinitionofthetargetvolumeinstereotacticradiotherapyforpancreaticadenocarcinomausingdifferentimagingmodalities AT fechtert interobserveragreementondefinitionofthetargetvolumeinstereotacticradiotherapyforpancreaticadenocarcinomausingdifferentimagingmodalities AT moustakisc interobserveragreementondefinitionofthetargetvolumeinstereotacticradiotherapyforpancreaticadenocarcinomausingdifferentimagingmodalities AT ernstf interobserveragreementondefinitionofthetargetvolumeinstereotacticradiotherapyforpancreaticadenocarcinomausingdifferentimagingmodalities AT bodaheggemannj interobserveragreementondefinitionofthetargetvolumeinstereotacticradiotherapyforpancreaticadenocarcinomausingdifferentimagingmodalities AT sarriag interobserveragreementondefinitionofthetargetvolumeinstereotacticradiotherapyforpancreaticadenocarcinomausingdifferentimagingmodalities AT dieckmannk interobserveragreementondefinitionofthetargetvolumeinstereotacticradiotherapyforpancreaticadenocarcinomausingdifferentimagingmodalities AT dobiaschs interobserveragreementondefinitionofthetargetvolumeinstereotacticradiotherapyforpancreaticadenocarcinomausingdifferentimagingmodalities AT dumamn interobserveragreementondefinitionofthetargetvolumeinstereotacticradiotherapyforpancreaticadenocarcinomausingdifferentimagingmodalities AT eberlef interobserveragreementondefinitionofthetargetvolumeinstereotacticradiotherapyforpancreaticadenocarcinomausingdifferentimagingmodalities AT kroegerk interobserveragreementondefinitionofthetargetvolumeinstereotacticradiotherapyforpancreaticadenocarcinomausingdifferentimagingmodalities AT hausslerb interobserveragreementondefinitionofthetargetvolumeinstereotacticradiotherapyforpancreaticadenocarcinomausingdifferentimagingmodalities AT izaguirrev interobserveragreementondefinitionofthetargetvolumeinstereotacticradiotherapyforpancreaticadenocarcinomausingdifferentimagingmodalities AT jazmatid interobserveragreementondefinitionofthetargetvolumeinstereotacticradiotherapyforpancreaticadenocarcinomausingdifferentimagingmodalities AT lautenschlagers interobserveragreementondefinitionofthetargetvolumeinstereotacticradiotherapyforpancreaticadenocarcinomausingdifferentimagingmodalities AT lohausf interobserveragreementondefinitionofthetargetvolumeinstereotacticradiotherapyforpancreaticadenocarcinomausingdifferentimagingmodalities AT mantelf interobserveragreementondefinitionofthetargetvolumeinstereotacticradiotherapyforpancreaticadenocarcinomausingdifferentimagingmodalities AT menzelj interobserveragreementondefinitionofthetargetvolumeinstereotacticradiotherapyforpancreaticadenocarcinomausingdifferentimagingmodalities AT pachmanns interobserveragreementondefinitionofthetargetvolumeinstereotacticradiotherapyforpancreaticadenocarcinomausingdifferentimagingmodalities AT pavicm interobserveragreementondefinitionofthetargetvolumeinstereotacticradiotherapyforpancreaticadenocarcinomausingdifferentimagingmodalities AT radlanskik interobserveragreementondefinitionofthetargetvolumeinstereotacticradiotherapyforpancreaticadenocarcinomausingdifferentimagingmodalities AT riesterero interobserveragreementondefinitionofthetargetvolumeinstereotacticradiotherapyforpancreaticadenocarcinomausingdifferentimagingmodalities AT gerums interobserveragreementondefinitionofthetargetvolumeinstereotacticradiotherapyforpancreaticadenocarcinomausingdifferentimagingmodalities AT roderf interobserveragreementondefinitionofthetargetvolumeinstereotacticradiotherapyforpancreaticadenocarcinomausingdifferentimagingmodalities AT willnerj interobserveragreementondefinitionofthetargetvolumeinstereotacticradiotherapyforpancreaticadenocarcinomausingdifferentimagingmodalities AT barczyks interobserveragreementondefinitionofthetargetvolumeinstereotacticradiotherapyforpancreaticadenocarcinomausingdifferentimagingmodalities AT imhoffd interobserveragreementondefinitionofthetargetvolumeinstereotacticradiotherapyforpancreaticadenocarcinomausingdifferentimagingmodalities AT blancko interobserveragreementondefinitionofthetargetvolumeinstereotacticradiotherapyforpancreaticadenocarcinomausingdifferentimagingmodalities AT wittiga interobserveragreementondefinitionofthetargetvolumeinstereotacticradiotherapyforpancreaticadenocarcinomausingdifferentimagingmodalities AT guckenbergerm interobserveragreementondefinitionofthetargetvolumeinstereotacticradiotherapyforpancreaticadenocarcinomausingdifferentimagingmodalities AT grosuancal interobserveragreementondefinitionofthetargetvolumeinstereotacticradiotherapyforpancreaticadenocarcinomausingdifferentimagingmodalities AT brunnertb interobserveragreementondefinitionofthetargetvolumeinstereotacticradiotherapyforpancreaticadenocarcinomausingdifferentimagingmodalities |